In contrast, in several transgenic mouse models of breast cancer, the consensus is that the CD24+/High sub-population rather than CD24Neg/Low sub-population enriches for TIC activities when CD24 is paired with either CD29 (ITGB1) or CD61 (ITGB3) [51–53]. This evidence concerns the gene ITGB3 and breast carcinoma.